Sanofi SNY
NASDAQ SNY
$42.48 -0.66 (-1.53%)
At close: Sep 18, 2026 · 4:00 PM EDT

Sanofi (SNY) Shares Outstanding (2009 - 2026)

Sanofi's (SNY) quarterly Shares Outstanding (Entity) came in at $1.2 billion in Q4 2025, down 3.46% year-over-year from $1.3 billion in Q4 2024, and down 3.46% quarter-over-quarter from $1.3 billion in Q4 2024.

Analysis

Sanofi (SNY) Shares Outstanding (2009 - 2026) Analysis & Trends

Sanofi has disclosed Shares Outstanding (Entity) across 17 years of filings, most recently posting $1.2 billion for Q4 2025.

  • In Q4 2025, Shares Outstanding (Entity) fell 3.46% year-over-year to $1.2 billion; the TTM figure through Dec 2025 stood at $1.2 billion (down 3.46% YoY), while the FY2025 annual figure was $1.2 billion, down 3.46% from the prior year.
  • Shares Outstanding (Entity) came in at $1.2 billion for Q4 2025 at Sanofi, down from $1.3 billion in the prior quarter.
  • In the past five years, Shares Outstanding (Entity) ranged from a high of $1.3 billion in Q4 2023 to a low of $1.2 billion in Q4 2025.
  • Average Shares Outstanding (Entity) over 5 years is $1.3 billion, with a median of $1.3 billion recorded in 2024.
  • Year-over-year, Shares Outstanding (Entity) increased 1.03% in 2021 and decreased 3.46% in 2025.
  • Over 5 years, Shares Outstanding (Entity) stood at $1.3 billion in 2021, then fell by 0.22% to $1.3 billion in 2022, then increased by 0.31% to $1.3 billion in 2023, then retreated by 0.13% to $1.3 billion in 2024, then decreased by 3.46% to $1.2 billion in 2025.
  • Per Business Quant data, the three most recent Shares Outstanding (Entity) figures were $1.2 billion in Q4 2025, $1.3 billion in Q4 2024, and $1.3 billion in Q4 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Johnson & Johnson 650.65 Bn 629.89 Bn 17.26 Bn 2.41 Bn
2 AbbVie 466.34 Bn 459.82 Bn 12.70 Bn 1.77 Bn
3 Merck 362.11 Bn 355.02 Bn 12.21 Bn 2.47 Bn
4 Novartis Ag 267.81 Bn 260.52 Bn 11.24 Bn 1.94 Bn
5 Pfizer 157.31 Bn 145.91 Bn 10.94 Bn 5.70 Bn
6 Bristol Myers Squibb 128.75 Bn 117.69 Bn 9.25 Bn 2.04 Bn
7 Sanofi 51.80 Bn 44.84 Bn 10.79 Bn 1.22 Bn
8 Revolution Medicines 40.91 Bn 40.91 Bn - 210.89 Mn
9 BeOne Medicines 39.65 Bn 34.55 Bn 1.53 Bn 111.58 Mn
10 Incyte 25.18 Bn 20.65 Bn 1.57 Bn 200.38 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.22 Bn
Mar 31, 2026 1.22 Bn
Dec 31, 2025 1.22 Bn
Sep 30, 2025 1.22 Bn
Jun 30, 2025 1.22 Bn
Mar 31, 2025 1.25 Bn
Dec 31, 2024 1.25 Bn
Sep 30, 2024 1.25 Bn
Jun 30, 2024 1.25 Bn
Mar 31, 2024 1.25 Bn
Dec 31, 2023 1.25 Bn
Sep 30, 2023 1.25 Bn
Jun 30, 2023 1.25 Bn
Mar 31, 2023 1.25 Bn
Dec 31, 2022 1.25 Bn
Sep 30, 2022 1.25 Bn
Jun 30, 2022 1.25 Bn
Mar 31, 2022 1.25 Bn
Dec 31, 2021 1.25 Bn
Sep 30, 2021 1.25 Bn